Skip to main content
TipRanks
Go Ultimate75% OFF

Allergy Therapeutics (AGYTF) Income Statement

2 Followers

Allergy Therapeutics Income Statement

Last quarter (Q4 2026), Allergy Therapeutics's total revenue was £23.59M, an increase of 9.07% from the same quarter last year. In Q4, Allergy Therapeutics's net income was £-31.59M. See Allergy Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJun 26Jun 25Jun 24Jun 23Jun 22
£ 59.87M£ 55.04M£ 55.20M£ 59.59M£ 72.77M
£ 24.78M£ 25.13M£ 29.74M£ 32.69M£ 48.95M
£ 65.75M£ 54.63M£ 64.99M£ 72.90M£ 61.95M
Depreciation and Amortization£ 4.64M£ 4.17M£ 4.32M£ 4.22M£ 4.17M
£ -36.34M£ -29.43M£ -30.74M£ -36.24M£ -8.69M
£ -40.98M£ -29.50M£ -35.26M£ -34.85M£ -13.00M
£ -11.44M£ -10.94M£ -3.91M£ -7.77M£ -396.00K
£ -52.41M£ -40.44M£ -39.17M£ -42.62M£ -13.40M
£ -51.51M£ -40.13M£ -40.22M£ -43.07M£ -13.78M
Per Share Metrics
Basic EPS£ -0.01£ -0.01£ -0.01£ -0.06£ -0.02
Diluted EPS£ -0.01£ -0.01£ -0.01£ -0.06£ -0.02
Weighted Average Shares Outstanding5.75B4.77B3.74B669.84M642.99M
Weighted Average Shares Outstanding (Diluted)5.75B4.77B3.74B670.36M642.99M

Currency in GBP

Allergy Therapeutics Earnings and Revenue History

-60M060M120M-100 %-50 %0 %50 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin